Case Report: Predominant Tubulointerstitial Lupus Nephritis or the Combination With IgG4-Related Disease?

Case Report: Predominant Tubulointerstitial Lupus Nephritis or the Combination With IgG4-Related Disease?

Isolated or dominant tubulointerstitial lupus nephritis is rare. Here, we reported a 67-year-old man diagnosed with systemic lupus erythematosus (SLE) based on clinical and laboratory criteria, who was showing impaired renal function and non-nephrotic range proteinuria in the past 2 years. Renal bio...

Full description

Bibliographic Details
Main Authors:	Ying Tan, Yan Qin, Xiao-juan Yu, Rong Xu, Su-xia Wang, Fu-de Zhou, Ming-hui Zhao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-06-01
Series:	Frontiers in Medicine
Subjects:	systemic lupus erythematosus lupus nephritis predominant interstitial nephritis IgG3 storiform pattern
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2021.684889/full

Similar Items

The predictive value of crescents in the disease progression of lupus nephritis based on the 2018 International Society of Nephrology/Renal Pathology Society Revision System: a large cohort study from China
by: Juan Tao, et al.
Published: (2020-01-01)

The Role of Anti-mCRP Autoantibodies in Lupus Nephritis
by: Mo Yuan, et al.
Published: (2023-05-01)

Tubulointerstitial lupus nephritis
by: Ala Ali, et al.
Published: (2013-01-01)

Case Report: A Rare Case of Lupus Nephritis Associated With Mantle Cell Lymphoma
by: Daorina Bao, et al.
Published: (2021-11-01)

Combination of anti-C1qA08 and anti-mCRP a.a.35-47 antibodies is associated with renal prognosis of patients with lupus nephritis
by: Xiao-Ling Liu, et al.
Published: (2023-04-01)

Hidden face of lupus nephritis exposed: Isolated tubulointerstitial lupus nephritis
by: Muhammed Mubarak
Published: (2013-01-01)

Lactococcus lactis subsp. lactis HFY14 Improves Renal Function in Mice with Lupus Nephritis
by: ZHAO Xin, ZHOU Yalin, FENG Xia
Published: (2023-03-01)

Exploratory study of serum IL-36 subfamily as biomarkers of disease progression in lupus nephritis
by: Chao Liu, et al.
Published: (2023-10-01)

C1q A08 Is a Half-Cryptic Epitope of Anti-C1q A08 Antibodies in Lupus Nephritis and Important for the Activation of Complement Classical Pathway
by: Wen-Jun Wu, et al.
Published: (2020-05-01)

Alterations of the gut microbiota in the lupus nephritis: a systematic review
by: Anjing Wang, et al.
Published: (2023-12-01)

Efficacy and safety of belimumab therapy in lupus nephritis: a systematic review and meta-analysis
by: Han Zhang, et al.
Published: (2023-12-01)

Lupus nephritis : frontiers and challenges /
by: Sheashaa, Hussein A.
Published: (2010)

Rapamycin relieves lupus nephritis by regulating TIM-3 and CD4+CD25+Foxp3+ Treg cells in an MRL/lpr mouse model
by: Yan-fang Gao, et al.
Published: (2022-09-01)

Noninvasive Evaluation of Lupus Nephritis Activity Using a Radiomics Machine Learning Model Based on Ultrasound
by: Qin X, et al.
Published: (2023-02-01)

Serum IgE anti-dsDNA autoantibodies in patients with proliferative lupus nephritis are associated with tubulointerstitial inflammation
by: Leran Chen, et al.
Published: (2023-12-01)

Case Report: Lenalidomide as a Second-Line Treatment for Bortezomib-Ineffective Nephrotic Syndrome Caused by LCDD: 2 Case Reports and a Literature Review
by: Xin Zhang, et al.
Published: (2021-10-01)

Effect of low and high HDL-C levels on the prognosis of lupus nephritis patients: a prospective cohort study
by: Peiran Yin, et al.
Published: (2017-12-01)

Renal microvascular lesions in lupus nephritis
by: Ying Ding, et al.
Published: (2020-01-01)

Clinical features and mortality in Chinese with lupus nephritis and neuropsychiatric lupus: A 124-patient study
by: Min Feng, et al.
Published: (2014-01-01)

Effect of phacoemulsification on corneal endothelium of cataract with lupus nephritis
by: Fen Ye, et al.
Published: (2014-09-01)

Increased Serum Levels of Soluble B7-H4 in Patients with Systemic Lupus Erythematosus
by: Jian-Ping Xiao, et al.
Published: (2019-03-01)

Urinary osteopontin predicted response to induction therapy and long-term renal outcomes in adults with lupus nephritis
by: Xiao-xue Wang, et al.
Published: (2023-10-01)

Angioimmunoblastic T-cell Lymphoma: A Mimic for Lupus
by: Hui Boon Tay, et al.
Published: (2020-07-01)

Clinical efficacy and safety of rituximab in lupus nephritis
by: Zhong Z, et al.
Published: (2019-03-01)

The relationship between cell apoptosis dysfunction and FEN1 E160D mutation in lupus nephritis patients
by: Jing Wang, et al.
Published: (2017-11-01)

Comparison of iguratimod and conventional cyclophosphamide with sequential azathioprine as treatment of active lupus nephritis: study protocol for a multi-center, randomized, controlled clinical trial (iGeLU study)
by: Qingran Yan, et al.
Published: (2021-08-01)

P-selectin blockade ameliorates lupus nephritis in MRL/lpr mice through improving renal hypoxia and evaluation using BOLD-MRI
by: Liwen Zhang, et al.
Published: (2020-03-01)

Lupus Nephritis in Males: Clinical Features, Course, and Prognostic Factors for End-Stage Renal Disease
by: Andrés Urrestarazú, et al.
Published: (2017-09-01)

Identification of new hub- ferroptosis-related genes in Lupus Nephritis
by: Xiao-Jie Zheng, et al.
Published: (2024-12-01)

LRCH1 maintains the function of regulatory T cells in mouse models of lupus nephritis
by: QIN Zhi-hui, TAN De-min, WANG Wang-zhen, ZHANG Yao
Published: (2022-03-01)

Analysis of factors associated with bone mineral density in patients with lupus nephritis
by: Xiao-na Zhan, et al.
Published: (2024-01-01)

Clinicopathological, Immunological, and Laboratory Parameters of Childhood Lupus Nephritis: A Study from Northeast India
by: Jonali Das, et al.
Published: (2023-09-01)

Drug-Induced Lupus Secondary to Ethosuximide in Association with Acute Tubulointerstitial Nephritis and Nephrotic Syndrome
by: Rasha Aly, et al.
Published: (2022-04-01)

Iguratimod as an alternative induction therapy for refractory lupus nephritis: a preliminary investigational study
by: Yuening Kang, et al.
Published: (2020-03-01)

USE OF RITUXIMAB IN PATIENTS WITH LUPUS NEPHRITIS
by: Anna Vasilyevna Torgashina, et al.
Published: (2010-08-01)

Anti‐dsDNA, anti‐nucleosome, anti‐C1q, and anti‐histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity
by: Xiaoying Shang, et al.
Published: (2021-06-01)

Lupus Nephritis, the therapy and the role of Rituximab in resistant cases
by: Hussein A. Nasir, et al.
Published: (2014-01-01)

Bradykinin 1 receptor blockade subdues systemic autoimmunity, renal inflammation, and blood pressure in murine lupus nephritis
by: Ling Qin, et al.
Published: (2019-01-01)

Prediction of treatment response in lupus nephritis using density of tubulointerstitial macrophage infiltration
by: Jingjing Wang, et al.
Published: (2024-02-01)

Interferon-λ3/4 genetic variants and interferon-λ3 serum levels are biomarkers of lupus nephritis and disease activity in Taiwanese
by: Ji-Yih Chen, et al.
Published: (2018-08-01)